MedPath

A Randomised Controlled Trial on the Effectiveness of Synbiotics on the Frequency and Duration of Loose Bowel Movement in Acute Adult Diarrheal Disease.

Phase 4
Completed
Conditions
loose bowel movement, acute adult diarrhea
Oral and Gastrointestinal - Normal oral and gastrointestinal development and function
Registration Number
ACTRN12607000296437
Lead Sponsor
Francel Villarin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
38
Inclusion Criteria

Angeles University Foundation Medical Center (AUFMC) and Rafael Lazatin Memorial Medical Center (RLMMC) patients, admitted for acute diarrheal disease from September 2006 to March 2007.Acute Diarrhea is defined as loose, watery, bowel movement of more than 3x a day non-bloody; loose watery bowel movement of 2 episodes more than patient’s usual BM.

Exclusion Criteria

Patients with co-morbidities, those who are diagnose with typhoid infections, amebiasis, no history or current antibiotics or antidiarrheal medication use, overflow diarrhea, antimotility intake, irritable bowel syndrome, history of diabetes mellitus, laxative abuse, malabsorption syndrome, thyroid pathology and those who are having diarrhea for more than a week.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparing stool consistency and frequency[After 6 month of study duration, all collected forms with randomically allocated numbers provided to the patients to answer will be collected by the authors unmasked, tabulated and and entered into a computer using SPSS for windows version 14 software. Wilcoxon Signed Rank test will be utilized for comparing stool consistency and frequency.];Comparing the clinical improvement of symptoms[After 6 month of study duration, all collected forms with randomically allocated numbers provided to the patients to answer will be collected by the authors unmasked, tabulated and and entered into a computer using SPSS for windows version 14 software. Sign test is use for comparing the clinical improvement of symptoms. Level of significance is set at 0.05.]
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes were not included in this study[]
© Copyright 2025. All Rights Reserved by MedPath